Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Simvastatin in Type 2 DM and Dyslipidemia
NCT00506961Phase 4Completed
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jun 2006
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin in dyslipidemia (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Percentage of patients achieving the combined treatment goal of LDL-C < 100mg/dl and non-HDL-C < 130 mg/dl at 12 weeks. Started Jun 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00506961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506961.